 "Inform people about vaccine in simple language, PM tells manufacturers")
Prime Minister Narendra Modi on Monday held a virtual meeting with three teams working on developing and manufacturing Covid-19 vaccine, and urged them to take extra efforts to inform people in simple language about the vaccine and related matters such as its efficacy.
The PM also asked the companies to come out with suggestions and ideas regarding the regulatory processes and related matters. These teams were from Gennova Biopharmaceuticals, Pune; Biological E, Hyderabad; and Dr Reddy's Laboratories, Hyderabad.
Ambassadors of 100 countries are scheduled to arrive in Pune on December 4 and visit Serum Institute of India and Gennova Biopharma, a press statement by the Prime Minister’s Office said.
Serum Institute in Pune will undertake mass production of Covishield vaccine developed by Oxford–Astra Zeneca. The prime minister visited the facility along with Zydus Biotech Park in Ahmedabad and Bharat Biotech in Hyderabad on Saturday to take stock of vaccine preparedness in the country.
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%